Loading color scheme

Changhung (Kevin) Chen, PHD

Senior Director of Preclinical Research   

Dr. Chen has over 20 years of research experience in T cell biology and developing antibody related immunotherapies targeting cancers and autoimmune diseases. Dr. Chen received his Ph.D degree in Microbiology and Immunology from Medical University of South Carolina. Dr. Chen completed his post-doctoral training at Yale University focusing on T cell activation/differentiation and continued his academic research at University of Washington focusing on the immune-modulating functions of dendritic cells. Before joining OncoC4, Dr. Chen has worked in several biotech companies where he established and developed therapeutic antibody research programs including bi-specific/multi-functional antibodies and CAR-T research.  At OncoC4, Dr. Chen is heading the research and development efforts on antibody products.